Q3 FY2022 · Quarterly report
80 pages
Read Alnylam Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this quarterly report
Create a free account to start reading
Full documents are included with Professional
Alnylam Pharmaceuticals, Inc.
165.00
USD
-9.00
(-5.17%)
Alnylam Pharmaceuticals, Inc. Documents
Q3 FY2022 documents
Earnings release
15 pages
Oct 27, 2022
Quarterly report
80 pages
Presentation
Alnylam Pharmaceuticals Inc - R&D Day 2022 - Conference Call Deck
179 pages
Presentation
Alnylam Pharmaceuticals Inc. - Special Call (3)
28 pages
Presentation
Alnylam Pharmaceuticals Inc - Q3 2022 - Conference Call Deck
32 pages
Presentation
Alnylam Pharmaceuticals Inc. - Special Call (2)
41 pages
Press release
6 pages
Dec 15, 2022